Cargando…
Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013953/ https://www.ncbi.nlm.nih.gov/pubmed/29929470 http://dx.doi.org/10.1186/s12882-018-0953-y |
_version_ | 1783334129366990848 |
---|---|
author | Shida, Haruki Hashimoto, Nobuhiro Kusunoki, Yoshihiro Hattanda, Fumihiko Ogawa, Yayoi Hayashi, Terumasa Nakazawa, Daigo Masuda, Sakiko Tomaru, Utano Ishizu, Akihiro |
author_facet | Shida, Haruki Hashimoto, Nobuhiro Kusunoki, Yoshihiro Hattanda, Fumihiko Ogawa, Yayoi Hayashi, Terumasa Nakazawa, Daigo Masuda, Sakiko Tomaru, Utano Ishizu, Akihiro |
author_sort | Shida, Haruki |
collection | PubMed |
description | BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction of anti-neutrophil cytoplasmic antibody (ANCA), to the hosts. Since ANCA can induce NET formation in the primed neutrophils, a positive feedback loop can be formed between NETs and ANCA, which is called “ANCA-NETs vicious cycle.” CASE PRESENTATION: A 79-year-old Japanese woman developed hydralazine-induced pauci-immune necrotizing crescentic glomerulonephritis with MPO-ANCA. Although the illness improved after cessation of hydralazine, MPO-ANCA-associated vasculitis relapsed 16 months later. Remission was achieved 5 months after beginning of administration of prednisone. In order to determine the involvement of ANCA-NETs vicious cycle in this patient, we examined NET degradation and induction activities in sera obtained at the disease onset (Serum A; MPO-ANCA, 107 IU/ml), at relapse (Serum B; MPO-ANCA, 195 IU/ml), at 3 months after treatment (Serum C; MPO-ANCA, 4.5 IU/ml), and at remission (Serum D; MPO-ANCA, 2.4 IU/ml). NET degradation activity was low in the all sera. NET induction activity was high in Sera A, B, and C but not in D. Additionally, we demonstrated the presence of anti-NET antibody (ANETA) in Sera B and C but not in A or D. CONCLUSIONS: The collective findings suggest NET induction potential of ANETA in the present patient and that the ANETA could contribute to the enhancement of NETs resulting in amplification of the ANCA-NETs vicious cycle. |
format | Online Article Text |
id | pubmed-6013953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60139532018-07-05 Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report Shida, Haruki Hashimoto, Nobuhiro Kusunoki, Yoshihiro Hattanda, Fumihiko Ogawa, Yayoi Hayashi, Terumasa Nakazawa, Daigo Masuda, Sakiko Tomaru, Utano Ishizu, Akihiro BMC Nephrol Case Report BACKGROUND: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction of anti-neutrophil cytoplasmic antibody (ANCA), to the hosts. Since ANCA can induce NET formation in the primed neutrophils, a positive feedback loop can be formed between NETs and ANCA, which is called “ANCA-NETs vicious cycle.” CASE PRESENTATION: A 79-year-old Japanese woman developed hydralazine-induced pauci-immune necrotizing crescentic glomerulonephritis with MPO-ANCA. Although the illness improved after cessation of hydralazine, MPO-ANCA-associated vasculitis relapsed 16 months later. Remission was achieved 5 months after beginning of administration of prednisone. In order to determine the involvement of ANCA-NETs vicious cycle in this patient, we examined NET degradation and induction activities in sera obtained at the disease onset (Serum A; MPO-ANCA, 107 IU/ml), at relapse (Serum B; MPO-ANCA, 195 IU/ml), at 3 months after treatment (Serum C; MPO-ANCA, 4.5 IU/ml), and at remission (Serum D; MPO-ANCA, 2.4 IU/ml). NET degradation activity was low in the all sera. NET induction activity was high in Sera A, B, and C but not in D. Additionally, we demonstrated the presence of anti-NET antibody (ANETA) in Sera B and C but not in A or D. CONCLUSIONS: The collective findings suggest NET induction potential of ANETA in the present patient and that the ANETA could contribute to the enhancement of NETs resulting in amplification of the ANCA-NETs vicious cycle. BioMed Central 2018-06-22 /pmc/articles/PMC6013953/ /pubmed/29929470 http://dx.doi.org/10.1186/s12882-018-0953-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Shida, Haruki Hashimoto, Nobuhiro Kusunoki, Yoshihiro Hattanda, Fumihiko Ogawa, Yayoi Hayashi, Terumasa Nakazawa, Daigo Masuda, Sakiko Tomaru, Utano Ishizu, Akihiro Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title | Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title_full | Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title_fullStr | Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title_full_unstemmed | Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title_short | Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
title_sort | anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013953/ https://www.ncbi.nlm.nih.gov/pubmed/29929470 http://dx.doi.org/10.1186/s12882-018-0953-y |
work_keys_str_mv | AT shidaharuki antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT hashimotonobuhiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT kusunokiyoshihiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT hattandafumihiko antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT ogawayayoi antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT hayashiterumasa antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT nakazawadaigo antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT masudasakiko antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT tomaruutano antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport AT ishizuakihiro antineutrophilextracellulartrapantibodyinapatientwithrelapseofantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport |